摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[[4-(4-cyanophenyl)piperazin-1-yl]methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-4-oxoquinolizine-3-carboxamide | 1309079-87-5

中文名称
——
中文别名
——
英文名称
1-[[4-(4-cyanophenyl)piperazin-1-yl]methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-4-oxoquinolizine-3-carboxamide
英文别名
——
1-[[4-(4-cyanophenyl)piperazin-1-yl]methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-4-oxoquinolizine-3-carboxamide化学式
CAS
1309079-87-5
化学式
C28H31N5O3
mdl
——
分子量
485.586
InChiKey
XXODCMADFJBDQF-AHWVRZQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    36
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    99.9
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    (1S,2S)-反式-1,3-氨基环己醇盐酸盐 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.5h, 生成 1-[[4-(4-cyanophenyl)piperazin-1-yl]methyl]-N-[(1S,2S)-2-hydroxycyclohexyl]-4-oxoquinolizine-3-carboxamide
    参考文献:
    名称:
    Identification of Amides as Carboxylic Acid Surrogates for Quinolizidinone-Based M1 Positive Allosteric Modulators
    摘要:
    Selective activation of the M-1 muscarinic receptor via positive allosteric modulation represents an approach to treat the cognitive decline in patients with Alzheimer's disease. A series of amides were examined as a replacement for the carboxylic acid moiety in a class of quinolizidinone carboxylic acid M-1 muscarinic receptor positive allosteric modulators, and leading pyran 4o and cyclohexane 5c were found to possess good potency and in vivo efficacy.
    DOI:
    10.1021/ml300280g
点击查看最新优质反应信息

文献信息

  • Identification of Amides as Carboxylic Acid Surrogates for Quinolizidinone-Based M<sub>1</sub> Positive Allosteric Modulators
    作者:Scott D. Kuduk、Ronald K. Chang、Thomas J. Greshock、William J. Ray、Lei Ma、Marion Wittmann、Matthew A. Seager、Kenneth A. Koeplinger、Charles D. Thompson、George D. Hartman、Mark T. Bilodeau
    DOI:10.1021/ml300280g
    日期:2012.12.13
    Selective activation of the M-1 muscarinic receptor via positive allosteric modulation represents an approach to treat the cognitive decline in patients with Alzheimer's disease. A series of amides were examined as a replacement for the carboxylic acid moiety in a class of quinolizidinone carboxylic acid M-1 muscarinic receptor positive allosteric modulators, and leading pyran 4o and cyclohexane 5c were found to possess good potency and in vivo efficacy.
查看更多